triazolopiridinas substituídas

The present invention relates to substituted triazolopyridine compounds of general formula (I): in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DIRK KOSEMUND, ANTJE MARGRET WENGNER, VOLKER SCHULZE, MARCUS KOPPITZ, SIMON HOLTON, HANS BRIEM, STEFAN PRECHTL, DETLEF DÖCKIGT, PHILIP LIENAU, BENJAMIN BADER, OLAF PRIEN, GERHARD SIEMEISTER, HARTMUT SCHIROK
Format: Patent
Sprache:por
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DIRK KOSEMUND
ANTJE MARGRET WENGNER
VOLKER SCHULZE
MARCUS KOPPITZ
SIMON HOLTON
HANS BRIEM
STEFAN PRECHTL
DETLEF DÖCKIGT
PHILIP LIENAU
BENJAMIN BADER
OLAF PRIEN
GERHARD SIEMEISTER
HARTMUT SCHIROK
description The present invention relates to substituted triazolopyridine compounds of general formula (I): in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease of uncontrolled cell growth, proliferation and/or survival as well as to the use of intermediate compounds for the preparation of said compounds.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112012031837A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112012031837A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112012031837A23</originalsourceid><addsrcrecordid>eNrjZJAvKcpMrMrPyS_ILMpMycxLLFYoLk0qLsksKT28NiWxmIeBNS0xpziVF0pzM6i6uYY4e-imFuTHpxYXJCan5qWWxDsFGRoaGQCRsaGFsbmjkTGx6gD7pygU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>triazolopiridinas substituídas</title><source>esp@cenet</source><creator>DIRK KOSEMUND ; ANTJE MARGRET WENGNER ; VOLKER SCHULZE ; MARCUS KOPPITZ ; SIMON HOLTON ; HANS BRIEM ; STEFAN PRECHTL ; DETLEF DÖCKIGT ; PHILIP LIENAU ; BENJAMIN BADER ; OLAF PRIEN ; GERHARD SIEMEISTER ; HARTMUT SCHIROK</creator><creatorcontrib>DIRK KOSEMUND ; ANTJE MARGRET WENGNER ; VOLKER SCHULZE ; MARCUS KOPPITZ ; SIMON HOLTON ; HANS BRIEM ; STEFAN PRECHTL ; DETLEF DÖCKIGT ; PHILIP LIENAU ; BENJAMIN BADER ; OLAF PRIEN ; GERHARD SIEMEISTER ; HARTMUT SCHIROK</creatorcontrib><description>The present invention relates to substituted triazolopyridine compounds of general formula (I): in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease of uncontrolled cell growth, proliferation and/or survival as well as to the use of intermediate compounds for the preparation of said compounds.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20161108&amp;DB=EPODOC&amp;CC=BR&amp;NR=112012031837A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20161108&amp;DB=EPODOC&amp;CC=BR&amp;NR=112012031837A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DIRK KOSEMUND</creatorcontrib><creatorcontrib>ANTJE MARGRET WENGNER</creatorcontrib><creatorcontrib>VOLKER SCHULZE</creatorcontrib><creatorcontrib>MARCUS KOPPITZ</creatorcontrib><creatorcontrib>SIMON HOLTON</creatorcontrib><creatorcontrib>HANS BRIEM</creatorcontrib><creatorcontrib>STEFAN PRECHTL</creatorcontrib><creatorcontrib>DETLEF DÖCKIGT</creatorcontrib><creatorcontrib>PHILIP LIENAU</creatorcontrib><creatorcontrib>BENJAMIN BADER</creatorcontrib><creatorcontrib>OLAF PRIEN</creatorcontrib><creatorcontrib>GERHARD SIEMEISTER</creatorcontrib><creatorcontrib>HARTMUT SCHIROK</creatorcontrib><title>triazolopiridinas substituídas</title><description>The present invention relates to substituted triazolopyridine compounds of general formula (I): in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease of uncontrolled cell growth, proliferation and/or survival as well as to the use of intermediate compounds for the preparation of said compounds.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAvKcpMrMrPyS_ILMpMycxLLFYoLk0qLsksKT28NiWxmIeBNS0xpziVF0pzM6i6uYY4e-imFuTHpxYXJCan5qWWxDsFGRoaGQCRsaGFsbmjkTGx6gD7pygU</recordid><startdate>20161108</startdate><enddate>20161108</enddate><creator>DIRK KOSEMUND</creator><creator>ANTJE MARGRET WENGNER</creator><creator>VOLKER SCHULZE</creator><creator>MARCUS KOPPITZ</creator><creator>SIMON HOLTON</creator><creator>HANS BRIEM</creator><creator>STEFAN PRECHTL</creator><creator>DETLEF DÖCKIGT</creator><creator>PHILIP LIENAU</creator><creator>BENJAMIN BADER</creator><creator>OLAF PRIEN</creator><creator>GERHARD SIEMEISTER</creator><creator>HARTMUT SCHIROK</creator><scope>EVB</scope></search><sort><creationdate>20161108</creationdate><title>triazolopiridinas substituídas</title><author>DIRK KOSEMUND ; ANTJE MARGRET WENGNER ; VOLKER SCHULZE ; MARCUS KOPPITZ ; SIMON HOLTON ; HANS BRIEM ; STEFAN PRECHTL ; DETLEF DÖCKIGT ; PHILIP LIENAU ; BENJAMIN BADER ; OLAF PRIEN ; GERHARD SIEMEISTER ; HARTMUT SCHIROK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112012031837A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DIRK KOSEMUND</creatorcontrib><creatorcontrib>ANTJE MARGRET WENGNER</creatorcontrib><creatorcontrib>VOLKER SCHULZE</creatorcontrib><creatorcontrib>MARCUS KOPPITZ</creatorcontrib><creatorcontrib>SIMON HOLTON</creatorcontrib><creatorcontrib>HANS BRIEM</creatorcontrib><creatorcontrib>STEFAN PRECHTL</creatorcontrib><creatorcontrib>DETLEF DÖCKIGT</creatorcontrib><creatorcontrib>PHILIP LIENAU</creatorcontrib><creatorcontrib>BENJAMIN BADER</creatorcontrib><creatorcontrib>OLAF PRIEN</creatorcontrib><creatorcontrib>GERHARD SIEMEISTER</creatorcontrib><creatorcontrib>HARTMUT SCHIROK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DIRK KOSEMUND</au><au>ANTJE MARGRET WENGNER</au><au>VOLKER SCHULZE</au><au>MARCUS KOPPITZ</au><au>SIMON HOLTON</au><au>HANS BRIEM</au><au>STEFAN PRECHTL</au><au>DETLEF DÖCKIGT</au><au>PHILIP LIENAU</au><au>BENJAMIN BADER</au><au>OLAF PRIEN</au><au>GERHARD SIEMEISTER</au><au>HARTMUT SCHIROK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>triazolopiridinas substituídas</title><date>2016-11-08</date><risdate>2016</risdate><abstract>The present invention relates to substituted triazolopyridine compounds of general formula (I): in which R1, R2, R3, R4, and R5 are as given in the description and in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds, to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease of uncontrolled cell growth, proliferation and/or survival as well as to the use of intermediate compounds for the preparation of said compounds.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_BR112012031837A2
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title triazolopiridinas substituídas
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A17%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DIRK%20KOSEMUND&rft.date=2016-11-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112012031837A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true